| NAME | CAS |
|
Benzyltriphenylphosphonium bromide
| 1449-46-3 |
|
Sodium Hydroxide 0.1N Solution
| 1310-73-2 |
|
Sodium Hydroxide 0.5 N
| 1310-73-2 |
|
Sodium Hydroxide 1N
| 1310-73-2 |
|
Lithium Standard
| 90-43-7 |
|
Dilutor Cleaning Solution
| 90-43-7 |
|
Calix[4]-bis-2,3-naphtho-crown-6
| 0-00-0 |
|
Calix[4]-bis-1,2-benzo-crown-6
| |
|
Calix[4]-bis-crown-6
| 157769-14-7 |
|
Broth (All Types-Both Liquid and Powder)
| |
|
Pumice
| 1332-09-8 |
|
Factor V Abnormal Control Level 1
| |
|
Barium manganate(vi), 95%
| 7787-35-1 |
|
Factor II Deficient Plasma
| |
|
Factor I Deficient Plasma
| |
|
Factor XII Deficient Plasma
| |
|
nTris(trimethylsilyl)silane, 96% (gc)
| 1873-77-4 |
|
Beta-(2-Thienyl)-Acrylic Acid, 98%
| 15690-25-2 |
|
Factor IX Abnormal Control Level 4
| |
|
Factor IX Abnormal Control Level 3
| |
|
Factor IX Abnormal Control Level 2
| |
|
Factor IX Abnormal Control Level 1
| |
|
Methyl 4-chlorobutyrate, 98+%
| 3153-37-5 |
|
Factor VIII Abnormal Control Level 4
| |
|
Factor VIII Abnormal Control Level 3
| |
|
Adipoyl chloride
| 111-50-2 |
|
1,12-Dibromododecane, 96 %
| 3344-70-5 |
|
Allyl Bromide
| 106-95-6 |
|
Alizarin Red S
| 130-22-3 |
|
Alginic acid
| 9005-38-3 |
|
DL-Isocitric Acid, Monopotassium Salt, 99%
| |
|
Alizarin
| 72-48-0 |
|
2-Bromobenzyl alcohol, 98%
| 18982-54-2 |
|
DL-Alanine
| 302-72-7 |
|
Albumin, Bovine (Fraction V)
| 9048-46-8 |
|
Kaolin Washed with Acid, Light
| 1332-58-7 |
|
Adenosine-5-Triphosphoric Acid Disodium Salt
| 987-65-5 |
|
0.02M (0.1N) Potassium Permanganate
| 7722-64-7 |
|
Acrylaldehyde
| 107-02-8 |
|
Acridine Orange
| 65-61-2 |
|
Zirconyl Chloride Octahydrate
| 7699-43-6 |
|
Zirconium Dioxide
| 1314-23-4 |
|
1,5-Diiodopentane, 98%
| 628-76-2 |
|
Buffer Solution pH 2.0
| 56-40-6 |
|
Sodium tetra-ethylborate
| 2679-89-2 |
|
2-(Methylamino)Isobutyric Acid, 99%
| 2566-34-9 |
|
Buffer Solution pH 3.0
| 877-24-7 |
|
Acetyl bromide
| 506-96-7 |
|
Buffer Solution pH 4.0
| 877-24-7 |
|
1-Acetoxy-2-Methoxyethane
| 110-49-6 |